Replies to post #174 on Opexa Therapeutics, Inc. (OPXA)

[io_io]

<"from 9 cents to 4 dollars"> ==> try $5 by 10am ?

<"He similarly expected partnering in the 2nd half of 2010. Do you think an announcement will come earlier?">

hi Biomund - well your question has been answered now !

<"How do you see this investment working out considering the long path ahead?">

It is actually still a cheap stock, and has two distinct programs. No doubt the Tovaxin one is the most difficult. I think though the CEO is totally honest, and these days they have to be - they are in partnership discussions. And it may take a long time, especially if it is Big Pharma - and a new concept, which this is.

[io_io]

OPXA cc today

http://www.meetmax.com/sched/wsaf809/investor_reg_new.html?event_id=3682&cmd=register

Well if personalized medicine is what counts, then everyone should listen to the description of how Tovaxin is manufactured, personal to the patient, and altered as needed on an annual basis.

Also the discussion and Q+A on the partnering process has me convinced that the talks are real, even if a deal is not imminent.